Literature DB >> 3001769

Isolation and purification of an endogenous brain ligand for benzodiazepine receptor(s).

J Y Wu, H S Lin, Y Y Su, C Y Yang.   

Abstract

An endogenous brain ligand which competes with 3H-flunitrazepine for the binding to benzodiazepine receptor has been isolated and purified to homogeneity. The purification procedures involve the liberation of the ligand into the high speed supernatant followed by ultrafiltration through a PM10 membrane (exclusion limit: 10,000-dalton) column chromatographies on Sephadex G-50, Bio-Rad P2 and finally with three times reversed phase HPLC using C18 columns. The purified endogenous ligand is heat stable, insensitive to DNAase or RNAase and contains about 5-10% amino acid residues. It has an absorption maximum at 220 nm and a minor peak at 313 nm. The exact chemical structure is unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001769

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  2 in total

1.  Purification and characterization of a benzodiazepine-like substance from mammalian brain.

Authors:  C C Liao; H S Lin; J Y Liu; L S Hibbard; J Y Wu
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

2.  Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding.

Authors:  J D Elsworth; D Dewar; V Glover; B L Goodwin; A Clow; M Sandler
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.